UN delays cloning vote

US speaks out in support of total cloning ban, vote may take place soon

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

UNITED NATIONS—The legal committee of the UN's General Assembly concluded the year's second day of debating whether to ban human cloning on Friday (October 22) without taking a vote, leaving the issue to percolate further in the minds of the deeply divided—and still undecided—member states.

On Friday, Susan Moore, the US Special Advisor, addressed the committee and reiterated the country's position in favor of the total cloning ban. Therapeutic cloning turns "nascent human life into a resource or commodity to be mined and exploited, eroding the sense of worth and dignity of the individual," she said. "For this reason, a partial ban that prohibits reproductive cloning but permits therapeutic, research, or experimental cloning is unacceptable to the United States and many other countries."

The UN has been trying to reach agreement on a convention for more than 2 years. On Thursday (October 21), UN Secretary General Kofi Annan announced that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform